Article_5_3_4
ORAL MEDICINE
SALIVARY MATRIX METALLOPROTEINASES ACTIVITY LEVELS IN
Original Article
AUTOIMMUNE DISEASES
Iulia-Ioana Stănescu1a , Alina Dima2b, Eugenia Bălănescu3b, Daniela Miricescu1c, Alexandra Totan1c, Radu Rădulescu1d,
Bogdan Calenic1e* , Paula Perlea4f, Daniela Bălan5g, Maria Greabu1h
1
Department of Biochemistry, Faculty of Dental Medicine, “Carol Davila” University of Medicine and Pharmacy, RO-050474 Bucharest, Romania
2
Department of Internal Medicine, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, RO-020125 Bucharest, Romania
3
Laboratory of Clinical Immunology, Colentina Clinical Hospital, RO-020125 Bucharest, Romania
4
Department of Endodontics, Faculty of Dental Medicine, “Carol Davila” University of Medicine and Pharmacy, RO-010221 Bucharest, Romania
5
Department of Physiology, Faculty of Dental Medicine, “Carol Davila” University of Medicine and Pharmacy, RO-010221 Bucharest, Romania
a
DDS, Assistant Professor
b
MD, PhD
c
PhD, Assistant Professor
d
DDS, PhD
e
DDS, PhD, Assistant Professor
f
DDS, PhD, Professor
g
MD, PhD, Assistant Professor
h
PhD, Professor, Head
ABSTRACT DOI: 10.25241/stomaeduj.2018.5(3).art.4
OPEN ACCESS This is an Open Access article
Introduction: It is widely recognized that saliva represents a solid alternative as a under the CC BY-NC 4.0 license.
diagnostic fluid in a wide range of oral and general diseases. Autoimmune diseases Peer-Reviewed Article
constitute an important health threat to both men and women worldwide with Citation: Stănescu I-I, Dima A, Bălănescu E, Miricescu D,
matrix metalloproteinases (MMPs) playing significant roles in pathogenesis and Totan A, Rădulescu R, Calenic B, Perlea P, Bălan D, Greabu
development of these diseases. The specific aim of the present study is to asses, M. Salivary matrix metalloproteinases activity levels in
autoimmune diseases. Stoma Edu J. 2018;5(3):168-172.
for the first time, salivary levels of a selected panel of MMPs in several autoimmune
diseases. Academic Editor: David Wray, MD (Honours), BDS, MB
ChB, FDS, RCPS (Glasgow), FDS RCS (Edinburgh) F Med
Methodology: The study included 30 patients divided into groups such as: Sci, Professor Emeritus, Professor, University of Glasgow,
Glasgow, UK
systemic sclerosis, vasculitis and healthy subjects. Salivary levels of MMP-1, -2, -7, -9
and -10 were analyzed using magnetic bead-based multiplex assays and Luminex Received: September 03, 2018
Revised: September 10, 2018
technology. Acccepted: September 24, 2018
Results: MMP-2 salivary levels were statistically elevated in systemic sclerosis, Published: September 25, 2018
while MMP-10 were also increased in vasculitis patients. Salivary levels of MMP-9 *Corresponding author: Assist. Professor Bogdan
were found significantly increased in all analyzed groups. Calenic, DDS, PhD, Department of Biochemistry, Faculty of
Dental Medicine, “Carol Davila” University of Medicine and
Conclusion: Taken together, our results promote saliva as a reliable diagnostic Pharmacy, RO-050474 Bucharest, Romania
fluid for quantifying MMPs in autoimmune diseases. Tel.:+40755044047, Fax: +40.213.110.984; e-mail:
bcalenic@yahoo.co.uk
Keywords: saliva, autoimmune diseases, matrixmetalloproteinase, vasculitis, systemic
Copyright: © 2018 the Editorial Council for the
sclerosis. Stomatology Edu Journal.
1. Introduction Scleroderma is considered a rare disease that affects
Over the past decades, saliva has become a hot topic the connective tissue. Depending on the extent of
in medical research related to discovering alternative the manifestations, scleroderma can be classified
diagnostic methods. Whole saliva is a complex fusion either as localized- when only the skin and in
of the fluid produced by major and minor salivary some cases the tissues underneath are involved, or
glands with gingival crevicular fluid, oral desquamated systemic sclerosis, a more complex form in which
cells, bacteria, as well as with food remains [1,2]. cutaneous manifestations are associated with visceral
The advantages provided by saliva as a diagnostic impairment. Theories regarding the etiology of this
fluid include non-invasive and effortless collection affliction have incriminated genetic factors, trauma,
procedures, the need for small samples for analysis, viral or bacterial infections, neurological damage or
along with easy storage and an established correlation vascular abnormalities. However, an increased level
between salivary and blood biomarkers’ levels [3]. of antinuclear antibodies, as well as the frequent
In addition to these benefits, its rich composition association with autoimmune diseases such as
consisting of electrolytes, proteins and hormones systemic vasculitis or systemic sclerosis, plead for an
deriving not only from oral sources, but also from autoimmune disease characterized by an inflammatory
systemic production, promote saliva as a remarkable phase followed by fibrosis, causing atypical collagen to
diagnosis and monitoring fluid for both local and replace normal dermis [9]. Vasculitis is a rare disease
general diseases [4-6]. However, few studies have characterized by an inflammatory process located
focused on the potential saliva has as a diagnostic fluid within the walls of blood vessels, affecting mainly small
for autoimmune diseases [7,8]. calibre vessels. The great diversity of the vessels affected
168 Stoma Edu J. 2018;5(3): 168-172 http://www.stomaeduj.com
SALIVARY MATRIX METALLOPROTEINASES ACTIVITY LEVELS IN
AUTOIMMUNE DISEASES
explains the clinical heterogeneity of this disease that
Original Article
Table 1. Clinical data of patients included in the study (autoimmune
involves a great variety of organs [10]. Meanwhile, disease group and control group).
matrix metalloproteinases (MMPs) represent a group Inclusion Disease
BMI,
of proteases produced by several types of cells, Cases age, duration,
kg/m2
including pro-inflammatory cells with multiple roles Years Years
such as leukocyte infiltration in conditions with an Total
63
53.0 8.0 25.5
inflammatory component [11]. To the best of our subjects (37.5 – 60.5) (4.0 – 14.0) (21.8 – 29.9)
knowledge up to the present, there are no scientific 52.0 2.0 25.9
SS 10
(40.0 – 60.0) (0.5 – 9.0) (22.4 – 30.9)
studies focusing on the salivary MMP levels in patients
with autoimmune diseases. 47.0 8.0 25.8
VA 10
(42.0 – 70.0) (2.0 – 14.0) (24.8 – 35.1)
Taking all this into consideration, the main objective of
45.0 21.9
the present research is to assess the potential use of saliva Control 10
(30.0 – 50.5)
-
(19.5 – 22.6)
as a diagnosis and monitoring fluid for autoimmune SS – systemic sclerosis; VA - vasculitis; BMI – body mass index; kg – kilogram;
diseases by evaluating salivary levels of a group of MMPs m – meter;
in patients with systemic sclerosis and vasculitis and
compare them with those of healthy subjects. Table 2. MMP levels in Systemic Sclerosis. SS n-10 cases.
MMP1 MMP2 * MMP7 MMP9 * MMP10 *
2. Material and methods 1424.43 24.3125 1093.68 6571.25 1796.62
2.1. Patient selection SS (1009.22- (19.32- (1003.02- (5894.31- (1221.33-
1994.30) 29.33) 1903.10) 7043.44) 1943.01)
Our study included a total of 30 patients: 10 patients
with systemic sclerosis and 10 vasculitis patients. 3565.167 10.3 1521.45 1148.5 943.82
10 healthy subjects, with no autoimmune disease, Control (1237.5- (3.45- (854.3- (843.4- (754.28-
represented the control group. Clinical data including 4422.5) 14.32) 2321.59) 2749.48) 1232.37)
age, gender, current treatments, as well as a series of Data are expressed as median (inferior; superior limits); * Mann-Whitney test;
biochemical and immunological parameters have p – value < 0.05 is considered statistically significant
been collected for all the participants to the study. All
Table 3. MMP levels in Vasculitis. VA n-10 cases.
subjects included in our research agreed to participate
voluntarily and signed an informed consent. The MMP1 MMP2 MMP7 MMP9 * MMP10 *
present research was approved by the ethics board
of Colentina Clinical Hospital, Bucharest, Romania. All 1899.7 25.4 1071 5551.7 2372.2
VA (1002.54- (10.22- (920.32- (4988.38- (2082.10-
patients were diagnosed by the same experienced 2540.9) 38.43) 1643.39) 5903.80) 3002.48)
medical professional.
3565.167 10.3 1521.45 1148.5 943.82
Control (1237.5- (3.45- (854.3- (843.4- (754.28-
2.2. Samples collection 4422.5) 14.32) 2321.59) 2749.48) 1232.37)
For all participants in the study, saliva samples
Data are expressed as median (inferior; superior limits); * Mann-Whitney test;
were collected at the moment of inclusion in the p – value < 0.05 is considered statistically significant
present study. Their written consent was taken prior
to collecting the samples. The collection method 20,000 pg/mL; MMP-2: 68 – 50,000 pg/mL; MMP-7: 548
followed a well-established protocol and took place as – 400,000 pg/mL; MMP-9: 14 – 10,000 pg/mL; MMP-
follows: 2-5 mL of unstimulated whole saliva was given 10: 27 – 20,000 pg/mL. The assay involved a two-hour
by each participant in the morning around 9 AM. The multistep procedure involving preparation of reagents,
participants were asked to refrain from eating, drinking samples and controls, preparation of the 96 well-plate
or smoking prior to saliva collection. All subjects rinsed and analysis using a Luminex® 200™ and the xPONENT®
with 5 mL of distilled water before collection. The software for data acquisition and analysis.
patients were also asked to sit down and be relaxed
during saliva sampling as well as not to communicate 2.4. Statistical analysis
with each other. Immediately after the collection, The statistical analysis was performed using SPSS
the samples were kept on ice and transported in an software. The characteristics were expressed as median
isotherm box and subsequently, they were centrifuged (quartile 1; 3). Statistically significant correlations
at 5000 rpm for 10 minutes. Samples were aliquoted were found using the Mann-Whitney test (a two-
and stored at -80ºC until further determinations. sided p-value less than 0.05 was noted as statistically
significant). A Spearman test was used to evaluate
2.3. Matrix metalloproteinases detection possible correlations between salivary MMPs levels,
All MMPs were detected using Luminex technology and as well as for other significant bivariate (p-value < 0.05
Magnetic Bead-Based Multiplex assays. This method was considered statistically significant).
enables the simultaneous detection of multiple salivary
human biomarkers. Thus salivary levels of MMP-1, -2,
-7, -9, -10 were assessed using MILLIPLEX MAP Human 3. Results
MMP Magnetic Bead Panel 2 - Immunology Multiplex 3.1. Clinical data
Assay. All samples and controls were processed Several clinical parameters such as body mass index, age
following the manufacturer's specifications. The assay at the moment of the diagnostic and at the inclusion as
required 25 μL of saliva diluted at 1:20; each MMP well as disease duration were recorded for all subjects in-
had its own detection interval as follows: MMP-1: 27 – cluded in the study (see Table 1).
Stomatology Edu Journal 169
SALIVARY MATRIX METALLOPROTEINASES ACTIVITY LEVELS IN
AUTOIMMUNE DISEASES
3.2. MMP-1, -2, -7, -9, 10 levels in Systemic Sclerosis
Original Article In the present study patients with SS showed a
Table 4. Increased salivary MMPs levels in autoimmune diseases
(increments are based on own results and are statistically significant at a p
statistical increment in salivary levels of MMP-2, -9 and < 0.05).
-10 when compared with respective controls. MMP-7
SS VA
was also increased, but with no statistical significance.
MMP-1 were statistically lower in the SS group vs the MMP-1 - -
control group (Table 2). MMP-2 ↑ 2 fold -
MMP-7 - -
3.3. MMP-1, -2, -7, -9, 10 levels in Vasculitis
Patients suffering from vasculitis had statistically MMP-9 ↑ 6 fold ↑ 4 fold
increased levels of MMP-9 and -10. At the same time, MMP-10 ↑ 2 fold ↑ 2 fold
the data were not statistically relevant for MMP-1, -2
and MMP-7 (Table 3). autoimmune disease. Moreover, salivary MMP-1 was
decreased SS and VA when compared to their controls,
but the results were not statistically significant. These
4. Discussion findings corroborated with existing scientific literature
In the past, blood serum has routinely been used in may suggest that MMP-1 does not play an active
the diagnostic process. However, most of the blood role in the pathogenesis of autoimmune diseases.
constituents are found in the saliva, as they pass Considering their organization, MMP-2 and MMP-9 are
through transcellular and paracellular routes. Nowadays considered gelatinases. MMP-2 plays important roles in
saliva could be introduced as a diagnostic tool in many both physiological processes such as angiogenesis and
medical fields including microbiology, immunology, in pathological situations like varicose veins disease,
oncology, endocrinology, etc. Saliva is easy to collect, inflammation, and cardiovascular diseases. Meanwhile,
ship and store; it could be obtained in sufficient MMP-9 in involved in cell apoptosis and osteoarthritis.
quantities at a low cost via non-invasive methods [12,13]. MMP-9 was shown to present higher levels in patients
Saliva-testing kits have been presented on the market, with systemic sclerosis [18]. Interestingly, in our study
although some of them are still waiting for approval. salivary MMP-9 levels were found statistically higher in
Intense efforts have been undertaken to detect markers all patient groups included in the study when compared
that reflect tumor pathologies such as oral cancers. The to the respective controls. Knowing that MMP-9 is
composition of saliva also reflects pathological changes generally involved in programmed cell death we can
in salivary glands. Salivary tumors can release in the infer that this marker is involved in tissue remodeling
salivary flow important levels of stathmin or maspin, processes occurring in these diseases. MMP-7 belongs
tumor necrosis factor, Dim1p, v-Ha-ras oncogene, type I to the matrilysins subgroup and has been linked to
collagen pro alpha or pirin [14]. Systemic cancers such as inflammation, lung disease, cardiovascular afflictions
breast, gastric or larynx neoplasm can also be detected and to physiological cell apoptosis. In the present study,
in saliva. p53 is a tumor suppressor protein capable of MMP-7 salivary levels were not statistically elevated in
blocking the tumor formation. Mutations in p53 gene any studied disease. MMP- 10 or stromelysin 2 has been
are found in most of the tumors and are associated linked to liver disease, viral infections, lung disease,
with tumor development and poor prognosis. p53 tissue remodeling and cell apoptosis and is considered
antibodies are found in the serum and saliva of patients to play an important role in peripheral arterial disease.
with oral squamous cell carcinoma [15]. Another marker Our findings show that MMP-10 salivary levels were
for oral squamous cell carcinoma identification, with significantly elevated when compared to controls in
significantly increased levels in saliva, is cortisol. The both systemic sclerosis and vasculitis patients.
marker is even frequently used for tumor staging. Some The present study has several limitations that will be
growth factors concentrations in saliva also correlate addressed in further studies: a larger number of patients
with the development of neoplasms. Elevated levels will be needed in the future to validate the present
of Fibroblast growth factor 2 (FGF2) correspond to findings. Future correlations with MMP serum levels in
salivary gland tumor growth. Sjögren syndrome, an all patients groups are needed in order to address the
autoimmune disease which among other effects alters possible utility of salivary MMPs in clinical settings.
the composition of saliva and tears is also studied
in association with reactive species of oxygen (ROS)
changes [16]. Several recent studies have shown that 5. Conclusion
the biomarker composition is different in saliva from In conclusion, the present study shows for the first time,
patients with Sjögren syndrome versus controls. Other that important matrix metalloproteinase is increased
studies analyzed saliva in connection with diseases such and can be detected in saliva from patients with
as Alzheimer, anorexia, bulimia of mental stress [17]. autoimmune diseases. Thus, salivary determination of
MMP-1 is a collagenase that normally can be found MMP-1, -2, -7, -9 and -10 promotes saliva as a viable
in low quantities in the cells, but increases its levels in alternative when determining the activity of these
autoimmune diseases as well as in inflammation. This enzymes in systemic sclerosis or vasculitis.
protease that degrades collagen plays an important role
in wound healing, immune response, inflammation,
fibrotic disorders and cardiovascular diseases. Moreover, Conflicts of Interest
MMP-1 could be involved in cancer. Our data did not The authors declare no conflict of interest.
show an increased activity of MMP-1 in any included
170 Stoma Edu J. 2018;5(3): 168-172 http://www.stomaeduj.com
SALIVARY MATRIX METALLOPROTEINASES ACTIVITY LEVELS IN
AUTOIMMUNE DISEASES
8. Bonamico M, Nenna R, Montuori M, et al. First salivary screening
Original Article
of celiac disease by detection of anti-transglutaminase
Author Contributions autoantibody radioimmunoassay in 5000 Italian primary
All authors equally contributed to the present schoolchildren. J Pediatr Gastroenterol Nutr. 2011;52(1):17-20.
manuscript. IIS: participated in study design, data doi: 10.1097/MPG.0b013e3181e6f2d0.
[Full text links] [PubMed] Google Scholar (53) Scopus (29)
collection, data interpretation and manuscript writing; 9. Careta MF, Romiti R. Localized scleroderma: clinical spectrum
AD: participated in study design and sample collection; and therapeutic update An Bras Dermatol. 2015;90(1):62-73. doi:
10.1590/abd1806-4841.20152890.
EB: participated in sample collection; DM: participated [Full text links] [Free PMC Article] [PubMed] Google Scholar (43)
in sample analysis and manuscript writing; AT: Scopus (25)
participated in manuscript writing; RR: participated in 10. McKinney EF, Willcocks LC, Broecker V, Smith KG. The
immunopathology of ANCA-associated vasculitis. Semin
data collection, data interpretation; BC: participated in Immunopathol. 2014;36(4):461-478. doi: 10.1007/s00281-014-
study design, data collection, data interpretation and 0436-6.
[Full text links] [Free PMC Article] [PubMed] Google Scholar (28)
manuscript writing; PP: participated in critical review Scopus (17)
of the manuscript; DB: participated in critical review of 11. Cui N, Hu M, Khalil RA. Biochemical and biological attributes of
the manuscript; MG: participated in study design, data matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1-
73. doi: 10.1016/bs.pmbts.2017.02.005.
collection, data interpretation and manuscript writing. [Full text links] [Free PMC Article] [PubMed] Google Scholar (23)
Scopus (14)
12. Dawes C, Pedersen AM, Villa A, et al. The functions of human
saliva: A review sponsored by the World Workshop on Oral
References Medicine VI. Arch Oral Biol. 2015J;60(6):863-874. doi: 10.1016/j.
1. Castagnola MP, Picciotti PM, Messana I, et al. Potential archoralbio.2015.03.004.
applications of human saliva as diagnostic fluid. Acta [Full text links] [PubMed] Google Scholar (118) Scopus (70)
Otorhinolaryngol Ital. 2011;31(6):347-357. 13. Javaid MA, Ahmed AS, Durand R, Tran SD. Saliva as a diagnostic
[Free PMC Article] [PubMed] Google Scholar (131) Scopus (68) tool for oral and systemic diseases. J Oral Biol Craniofac Res.
2. Nunes LA, Mussavira S, Bindhu OS. Clinical and diagnostic utility 2016;6(1):66-75. doi: 10.1016/j.jobcr.2015.08.006.
of saliva as a non-invasive diagnostic fluid: a systematic review. [Full text links] [Free PMC Article] [PubMed] Google Scholar (61)
Biochem Med. (Zagreb). 2015;25(2):177-192. doi: 10.11613/ Scopus (37)
BM.2015.018. eCollection 2015. 14. Cheng YS, Rees T, Wright J. A review of research on salivary
[Full text links] [Free PMC Article] [PubMed] Google Scholar (90) biomarkers for oral cancer detection. Clin Transl Med.
Scopus (59) 2014;3(1):3. doi: 10.1186/2001-1326-3-3.
3. Yoshizawa JM, Schafer CA, Schafer JJ, et al. Salivary biomarkers: [Full text links] [PubMed] Google Scholar (110)
toward future clinical and diagnostic utilities. Clin Microbiol Rev. 15. Aoyama I, Yaegaki K, Calenic B, et al. The role of p53 in an
2013;26(4):781-791. doi: 10.1128/CMR.00021-13. apoptotic process caused by an oral malodorous compound
[Full text links] [Free PMC Article] [PubMed] Google Scholar (155) in periodontal tissues: a review. J. Breath Res. 2012;6(1):017104.
Scopus (96) doi: 10.1088/1752-7155/6/1/017104.
4. Stănescu II, Calenic, B, Dima A, et al. Saliva as a monitoring fluid [Full text links] [PubMed] Google Scholar (14) Scopus (7)
for hormonal activity in systemic lupus erythematosus. REV 16. Wang J, Schipper HM, Velly AM, et al. Salivary biomarkers
CHIM. (Bucharest). 2018;69(3):654-659. of oxidative stress: A critical review. Free Radic Biol Med.
Google Scholar (0) Scopus (0) 2015;85:95-104. doi: 10.1016/j.freeradbiomed.2015.04.005.
5. Stănescu II, Calenic B, Dima A, et al. Salivary biomarkers of [Full text links] [PubMed] Google Scholar (35) Scopus (20)
inflammation in systemic lupus erythematosus. Ann Anat. 17. Malathi N, Mythili S, Vasanthi HR. Salivary diagnostics:
2018;219:89-93. doi: 10.1016/j.aanat.2018.02.012. a brief review. ISRN Dent. 2014;2014:158786. doi:
[Full text links] [PubMed] Google Scholar (0) Scopus (0) 10.1155/2014/158786. eCollection 2014.
6. Pfaffe T, Cooper-White J, Beyerlein P, et al. Diagnostic potential [Full text links] [Free PMC Article] [PubMed] Google Scholar (65)
of saliva: current state and future applications. Clin Chem. 18. Kim WU, Min SY, Cho ML, et al. Elevated matrix
2011;57(5):675-687. doi: 10.1373/clinchem.2010.153767. metalloproteinase-9 in patients with systemic sclerosis. Arthritis
[Full text links] [PubMed] Google Scholar (406) Scopus (257) Res Ther. 2005;7(1):R71-9. doi: 10.1186/ar1454.
7. Hu S, Vissink A, Arellano M, et al. Identification of autoantibody [Full text links] [Free PMC Article] [PubMed] Google Scholar (86)
biomarkers for primary Sjögren's syndrome using protein Scopus (61)
microarrays. Proteomics. 2011;11(8):1499-1507. doi: 10.1002/
pmic.201000206.
[Full text links] [Free PMC Article] [PubMed] Google Scholar (80)
Scopus (59)
Iulia-Ioana STĂNESCU
DDS, Assistant Lecturer
Department of Biochemistry, Faculty of Dental Medicine
“Carol Davila” University of Medicine and Pharmacy
Bucharest, Romania
CV
Iulia-Ioana Stănescu is a dentist, currently a PhD candidate in the field of Biochemistry and an Assistant Lecturer in the
Department of Physiology at the Faculty of Dental Medicine, “Carol Davila” University of Medicine and Pharmacy, Bucharest,
Romania. She graduated from the Faculty of Dental Medicine, “Carol Davila” University of Medicine and Pharmacy in dentistry
and her field of interest in her research as a PhD candidate is salivary diagnosis in autoimmune diseases.
Stomatology Edu Journal 171
SALIVARY MATRIX METALLOPROTEINASES ACTIVITY LEVELS IN
AUTOIMMUNE DISEASES
Questions
Original Article
1. Saliva is:
qa. A reliable diagnostic fluid containing biomarkers that statistically correlate with those found in blood;
qb. Not a reliable diagnostic fluid containing biomarkers that statistically correlate with those found in
blood;
qc. A fluid produced by major and minor salivary glands with gingival crevicular fluid, oral desquamated
cells, but not oral bacteria;
qd. An invasive method of collection.
2. Vasculitis:
qa. Is a common autoimmune disease;
qb. Usually affects large blood vessels;
qc. Can affect only a few organs;
qd. Is located in the walls of blood vessels.
3. MMP-2 is:
qa. Increased 2 fold in saliva from patients with vasculitis;
qb. Increased 2 fold in saliva from patients with systemic sclerosis;
qc. Not statistically increased in saliva samples taken from patients with autoimune diseases;
qd. Not a gelatinase.
4. MMP-9 is:
qa. Increased 6 fold in saliva from patients with systemic sclerosis;
qb. Increased 2 fold in in saliva from patients with systemic sclerosis;
qc. Statistically decreased in saliva samples taken from patients with autoimune diseases;
qd. Not involved in apoptosis.
http://www.quintpub.com/grunder/
172 Stoma Edu J. 2018;5(3):168-172 http://www.stomaeduj.com